Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 50.42 | 52.13 | 59.70 | 53.70 |
Total Revenue | 50.42 | 52.13 | 59.70 | 53.70 |
Costof Revenue Total | 6.59 | 40.47 | 67.90 | 45.36 |
Gross Profit | 43.83 | 11.66 | -8.19 | 8.34 |
Selling/ General/ Admin Expenses Total | 16.47 | 27.28 | 25.62 | 25.87 |
Depreciation/ Amortization | 6.77 | 6.56 | 6.30 | 5.12 |
Other Operating Expenses Total | 36.08 | 0.16 | 0.18 | 0.05 |
Total Operating Expense | 65.91 | 74.47 | 99.99 | 76.40 |
Operating Income | -15.49 | -22.34 | -40.29 | -22.70 |
Interest Inc( Exp) Net- Non- Op Total | -46.89 | -19.62 | -41.56 | -43.31 |
Other Net | 0.45 | -0.39 | -0.08 | -1.33 |
Net Income Before Taxes | -19.73 | -24.69 | -44.53 | -28.36 |
Provisionfor Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income After Taxes | -19.73 | -24.69 | -44.53 | -28.36 |
Net Income Before Extra Items | -19.73 | -24.69 | -44.53 | -28.36 |
Net Income | -19.73 | -24.69 | -44.53 | -28.36 |
Income Availableto Com Excl Extra Ord | -19.73 | -24.69 | -44.53 | -28.36 |
Income Availableto Com Incl Extra Ord | -19.73 | -24.69 | -44.53 | -28.36 |
Diluted Net Income | -19.73 | -24.69 | -44.53 | -28.36 |
Diluted Weighted Average Shares | 2.15 | 2.19 | 2.16 | 1.96 |
Diluted EPS Excluding Extra Ord Items | -9.16 | -11.30 | -20.65 | -14.45 |
Diluted Normalized EPS | -9.16 | -11.30 | -20.65 | -14.45 |
Unusual Expense( Income) | - | 0.00 | 0.00 | 0.00 |
Gain( Loss)on Saleof Assets | - | - | - | 0.00 |
Krebs Biochemicals & Industr Dividend Krebs Biochemicals & Industr Bonus Krebs Biochemicals & Industr News Krebs Biochemicals & Industr AGM Krebs Biochemicals & Industr Rights Krebs Biochemicals & Industr Splits Krebs Biochemicals & Industr Board Meetings Krebs Biochemicals & Industr Key Metrics Krebs Biochemicals & Industr Shareholdings Krebs Biochemicals & Industr Balance Sheet Krebs Biochemicals & Industr Cashflow Krebs Biochemicals & Industr Q1 Results Krebs Biochemicals & Industr Q2 Results Krebs Biochemicals & Industr Q3 Results Krebs Biochemicals & Industr Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks